C World Wide Group Holding A Exact Sciences Corp Transaction History

C World Wide Group Holding A

  • $8.06 Billion
  • Q1 2025

A detailed history of C World Wide Group Holding A transactions in Exact Sciences Corp stock. As of the latest transaction made, C World Wide Group Holding A holds 836,618 shares of EXAS stock, worth $43.8 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
836,618
Previous 836,618 -0.0%
Holding current value
$43.8 Million
Previous $47 Million 22.96%
% of portfolio
0.45%
Previous 0.57%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
$49.33 - $71.97 $32.8 Million - $47.8 Million
-664,211 Reduced 44.26%
836,618 $47 Million
Q3 2024

Nov 05, 2024
SELL
$42.43 - $70.83 $149,608 - $249,746
-3,526 Reduced 0.23%
1,500,829 $102 Million
Q2 2024

Jul 31, 2024
BUY
$41.33 - $74.26 $15.1 Million - $27.2 Million
366,385 Added 32.2%
1,504,355 $63.6 Million
Q1 2024

May 03, 2024
BUY
$56.27 - $73.77 $28.5 Million - $37.3 Million
505,797 Added 80.01%
1,137,970 $78.6 Million
Q3 2023

Nov 03, 2023
SELL
$65.94 - $99.04 $2.62 Million - $3.93 Million
-39,673 Reduced 5.91%
632,173 $43.1 Million
Q2 2023

Aug 02, 2023
SELL
$62.68 - $95.05 $1.04 Million - $1.57 Million
-16,552 Reduced 2.4%
671,846 $63.1 Million
Q1 2023

May 02, 2023
BUY
$47.19 - $70.77 $3.29 Million - $4.93 Million
69,706 Added 11.27%
688,398 $46.7 Million
Q4 2022

Feb 03, 2023
SELL
$30.35 - $53.15 $6,130 - $10,736
-202 Reduced 0.03%
618,692 $30.6 Million
Q3 2022

Nov 03, 2022
BUY
$31.97 - $49.37 $5.43 Million - $8.39 Million
170,000 Added 37.87%
618,894 $20.1 Million
Q2 2022

Aug 02, 2022
BUY
$35.61 - $76.23 $3.87 Million - $8.29 Million
108,689 Added 31.95%
448,894 $17.7 Million
Q1 2022

May 04, 2022
BUY
$57.56 - $82.54 $452,651 - $649,094
7,864 Added 2.37%
340,205 $23.8 Million
Q4 2021

Feb 02, 2022
BUY
$72.5 - $100.68 $4.99 Million - $6.94 Million
68,889 Added 26.15%
332,341 $25.9 Million
Q3 2021

Nov 01, 2021
BUY
$90.24 - $124.05 $82,208 - $113,009
911 Added 0.35%
263,452 $25.1 Million
Q2 2021

Aug 04, 2021
BUY
$93.66 - $139.27 $531,707 - $790,635
5,677 Added 2.21%
262,541 $32.6 Million
Q1 2021

May 04, 2021
SELL
$116.57 - $155.01 $3.5 Million - $4.65 Million
-30,000 Reduced 10.46%
256,864 $33.9 Million
Q4 2020

Feb 05, 2021
SELL
$99.61 - $142.12 $9.46 Million - $13.5 Million
-95,000 Reduced 24.88%
286,864 $38 Million
Q3 2020

Nov 02, 2020
BUY
$72.92 - $102.01 $6.73 Million - $9.41 Million
92,234 Added 31.85%
381,864 $38.9 Million
Q2 2020

Aug 05, 2020
SELL
$55.75 - $92.75 $2.51 Million - $4.17 Million
-45,000 Reduced 13.45%
289,630 $25.2 Million
Q1 2020

May 04, 2020
BUY
$37.9 - $104.44 $5.9 Million - $16.3 Million
155,698 Added 87.02%
334,630 $19.4 Million
Q2 2019

Aug 02, 2019
BUY
$89.51 - $118.04 $10.7 Million - $14.2 Million
120,000 Added 203.62%
178,932 $21.1 Million
Q1 2019

May 03, 2019
SELL
$61.98 - $96.5 $582,550 - $907,003
-9,399 Reduced 13.76%
58,932 $5.11 Million
Q4 2018

Feb 12, 2019
SELL
$56.04 - $82.66 $1.36 Million - $2 Million
-24,241 Reduced 26.19%
68,331 $4.31 Million
Q3 2018

Nov 05, 2018
SELL
$48.29 - $80.6 $971,932 - $1.62 Million
-20,127 Reduced 17.86%
92,572 $7.31 Million
Q2 2018

Aug 03, 2018
BUY
$37.84 - $69.96 $908,387 - $1.68 Million
24,006 Added 27.07%
112,699 $6.74 Million
Q1 2018

May 03, 2018
BUY
$39.82 - $57.53 $612,551 - $884,983
15,383 Added 20.98%
88,693 $3.58 Million
Q4 2017

Feb 07, 2018
SELL
$46.49 - $60.51 $3.71 Million - $4.83 Million
-79,820 Reduced 52.13%
73,310 $3.85 Million
Q3 2017

Nov 06, 2017
BUY
$37.05 - $47.12 $5.67 Million - $7.22 Million
153,130
153,130 $7.22 Million

Others Institutions Holding EXAS

# of Institutions
645
Shares Held
157M
Call Options Held
1.74M
Put Options Held
1.56M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.26B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email